Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Adrian Toutoungi

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Dr. Angela Knierim

Collaborateur senior

Read More

Barbora Dubanská, LL.M., MHA, Ph.D.

Associé

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More
Auteurs

David Mulder

Collaborateur senior

Read More

Christian Dekoninck

Associé

Read More

Adrian Toutoungi

Associé

Read More

Dr. Anja Lunze, LL.M.

Associé

Read More

Dr. Angela Knierim

Collaborateur senior

Read More

Barbora Dubanská, LL.M., MHA, Ph.D.

Associé

Read More

Agnieszka Sztoldman

Collaborateur senior

Read More

23 novembre 2020

Pharmaceutical patent law – 2 de 2 Publications

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

Dans cette série

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Brevets et innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9 novembre 2020
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus
warsaw
Sciences de la vie et Santé

CJEU ruling to liberalise parallel import in Poland

25 août 2020
IN-DEPTH ANALYSIS

par Agnieszka Sztoldman

Cliquer ici pour en savoir plus
pills
Coronavirus

Patent law in emergency situations

14 juillet 2020
QUICK READ

par David Mulder

Cliquer ici pour en savoir plus